ReviewCell death and differentiation2022

What can we learn from mice lacking pro-survival BCL-2 proteins to advance BH3 mimetic drugs for cancer therapy?

Kerstin Brinkmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.